Finance

Lists
002294:SHE
Shenzhen Salubris Pharmaceuticals Co Ltd
30,84 CN¥
+0,85%
(+0,26) 1D
16 հոկ, 15:04:54 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002294...
Open
30,83 CN¥
High
31,80 CN¥
Low
30,82 CN¥
Mkt. cap
34,38 մլրդ
Avg. vol.
9,55 մլն
Volume
27,91 մլն
Dividend
1,78%
Quarterly dividend
0,14 CN¥
Ex-dividend date
26 մյս, 2026 թ.
P/E ratio
51,05
52-wk high
70,99 CN¥
52-wk low
29,25 CN¥
EPS
0,60 CN¥
Shares outstanding
1,11 մլրդ
No. of employees
4 հզր
Open
30,83 CN¥
High
31,80 CN¥
Low
30,82 CN¥
Mkt. cap
34,38 մլրդ
Avg. vol.
9,55 մլն
Volume
27,91 մլն
Dividend
1,78%
Quarterly dividend
0,14 CN¥
Ex-dividend date
26 մյս, 2026 թ.
P/E ratio
51,05
52-wk high
70,99 CN¥
52-wk low
29,25 CN¥
EPS
0,60 CN¥
Shares outstanding
1,11 մլրդ
No. of employees
4 հզր
News stories
From web sources and news partners
Profile
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company. Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019. Shenzhen Salubris is headed by the billionaire Ye Chenghai. Wikipedia
About Shenzhen Salubris Pharmaceuticals Co Ltd
CEO-
Employees4,09 հզր
Founded03 նոյ, 1998 թ.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,11 մլրդ
1,11 մլրդ
1,23 մլրդ
1,25 մլրդ
Cost of goods sold
279,29 մլն
302,88 մլն
287,67 մլն
343,20 մլն
Cost of revenue
279,29 մլն
302,88 մլն
287,67 մլն
343,20 մլն
Research and development expenses
127,63 մլն
176,44 մլն
131,32 մլն
139,63 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
486,77 մլն
568,30 մլն
551,61 մլն
596,71 մլն
Operating expense
595,66 մլն
770,11 մլն
694,36 մլն
749,18 մլն
Total operating expenses
874,96 մլն
1,07 մլրդ
982,03 մլն
1,09 մլրդ
Operating income
235,37 մլն
38,38 մլն
246,41 մլն
158,32 մլն
Other non operating income
-14,62 մլն
13,83 մլն
-5,27 մլն
5,40 մլն
EBT including unusual items
234,09 մլն
5,21 մլն
255,47 մլն
142,37 մլն
EBT excluding unusual items
246,15 մլն
72,00 մլն
252,02 մլն
160,96 մլն
Income tax expense
18,06 մլն
-56,18 մլն
29,65 մլն
-22,28 մլն
Effective tax rate
7,72%
-1 078,48%
11,60%
-15,65%
Other operating expenses
-17,83 մլն
34,11 մլն
9,61 մլն
16,33 մլն
Net income
215,63 մլն
70,80 մլն
225,27 մլն
161,82 մլն
Net profit margin
19,42%
6,37%
18,34%
12,94%
Earnings per share
-
-
-
-
Interest and investment income
26,87 մլն
37,76 մլն
15,05 մլն
12,29 մլն
Interest expense
-4,88 մլն
-7,50 մլն
-4,17 մլն
-4,97 մլն
Net interest expenses
22,00 մլն
30,27 մլն
10,88 մլն
7,32 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
325,52 մլն
135,48 մլն
343,52 մլն
257,90 մլն
Gain or loss from assets sale
-983,77 հզր
3,03 մլն
-
166,24 հզր
AI content may include mistakes. Learn more
Google Apps